PSIL AdvisorShares Psychedelics ETF

Share ▾
Share on XDownload as PDF
$19.66
+0.8% · 1 day, price
IQ’s readingComputed nightly from ETFIQ data. Not written live.

Between Jun 30, 2026 and Oct 16, 2026, PSIL lost 17.3%, against −23.7% for its own holdings.

Holds 27 stocks in therapeutics and medical devices, 8% of its weight in S&P 500 companiesAdvisorShares ↗Expense ratio 1.00%Fund assets $43m on Nov 4, 2026First traded Sep 16, 2021Benchmark Its own holdings, as of Jun 30, 2026; its shareholder report compares it with the S&P 500 Index, but its daily returns fit VOO's at R-squared 0.148 over the year to Nov 4, 2026 (251 days), under the 0.35 it needs to return to itFund page at the issuer ↗SEC filings ↗Every AdvisorShares fund ETFIQ coversDividend history

Promise check: Not measuredETFIQ has not yet listed which companies belong to the therapeutics and medical devices theme.

PSIL risk and return scorecard

vs VOO, its stated benchmark (secondary) · Sep 2021 to Oct 2026 · 266 weekly returns · dividend-adjusted

5.1 years
PSIL −74.6%, VOO +82.6%, Sep 2021 to Oct 2026, distributions reinvested.

Secondary: VOO tracks the S&P 500 Index, named in its shareholder report. Its own benchmark is its holdings, which have no weekly prices.

Return
MeasurePSILVOOEdge
Total return−74.6%+82.6%VOO
Annualized−23.5%+12.5%VOO
Price return−78.1%+69.7%VOO
Risk
MeasurePSILVOOEdge
Volatility51.6%16.1%VOO
Max drawdown−92.6%−23.9%VOO
Upside capture39.7%100.0%VOO
Downside capture119.2%100.0%VOO
Risk-adjusted
MeasurePSILVOOEdge
Sharpe ratio−0.370.57VOO
Sortino ratio−0.640.85VOO
Alpha vs VOO
MeasurePSILVOOEdge
Alpha, a year−27.2%Not significant
Alpha t-stat−1.23
Beta to VOO0.881.00Lower beta

Computed by ETFIQ from Tiingo daily prices and ETFIQ's distribution records; risk-free rate: U.S. Treasury, Daily Treasury Bill Rates, 13-week coupon equivalent Method · Data

Money in and out

Net fund flows · Jun 30, 2026
12 months to Jun 30, 2026
+$22.3m
3 years to Jun 30, 2026
+$26.9m
5 years to Jun 30, 2026
+$45.3m

What you earned

PSIL −9.0%: total return over one month to Nov 4, 2026.
PSIL−9.0%
PSIL −20.3%: total return over three months to Nov 4, 2026.
PSIL−20.3%
PSIL −5.0%: total return over six months to Nov 4, 2026.
PSIL−5.0%
PSIL +14.5%: total return over the year to Nov 4, 2026.
PSIL+14.5%
PSIL +13.9%: total return over one year to Nov 4, 2026.
PSIL+13.9%
PSIL +49.7%: total return over three years to Nov 4, 2026.
PSIL+49.7%
PSIL −77.4%: total return over five years to Nov 4, 2026.
PSIL−77.4%
PSIL −77.2%: total return since launch to Nov 4, 2026.
PSIL−77.2%

What did you actually buy?

Therapeutics and medical devices · holdings as of Jun 30, 2026
7.8%
Already in the S&P 500
98.4%
Active share vs the S&P 500
69.2%
Top ten holdings
+13.9%
Total return, 1 year
8.9%
12-month yield, capital gains included, on its starting price
$1.6839
Last payment (paid quarterly), ex-date Dec 22, 2025
Share already in the S&P 500
7.8% of the fund by weight, holdings as of Jun 30, 2026.
Ten largest holdings
DEFINIUM THERAPEUTICS INC12.8%
COMPASS PATHWAYS PLC11.4%
ATAIBECKLEY INC10.5%
RELMADA THERAPEUTICS INC6.8%
NRX PHARMACEUTICALS INC6.1%
NEUROCRINE BIOSCIENCES INC4.4%
CYBIN INC4.3%
GH RESEARCH PLC4.3%
ALKERMES PLC4.3%
ALTO NEUROSCIENCE INC4.2%

More on PSIL

Every number below is on this page. Open what you need.

The week's ETF fund flows, by email on Sundays.

One-click unsubscribe. See Privacy.

Price and total return, 1 year

$19.66+0.8%1 day, priceClose, Nov 4, 2026

Total return adds every distribution, reinvested. Computed by ETFIQ from Tiingo daily prices.

Source: Tiingo end-of-day prices. Data as of Nov 4, 2026. Updated every trading night. Report a data error

Points (pts) are percentage points.

PSIL returns by window: total return, cash paid and price change
WindowTotal returnS&P 500 (SPY)
1M Oct 5 – Nov 4, 2026−9.0%−1.0%
3M Aug 5 – Nov 4, 2026−20.3%−0.1%
6M May 6 – Nov 4, 2026−5.0%+5.0%
YTD Dec 31, 2025 – Nov 4, 2026+14.5%+13.3%
1Y Nov 4, 2025 – Nov 4, 2026+13.9%+14.8%
3Y Nov 3, 2023 – Nov 4, 2026+49.7%+82.9%
5Y Nov 5, 2021 – Nov 4, 2026−77.4%+75.0%
Since launch Sep 16, 2021 – Nov 4, 2026−77.2%+84.0%
Since launch, annualised Sep 16, 2021 – Nov 4, 2026−25.0%–

Total returns, distributions reinvested.

Source: Tiingo end-of-day prices, with distributions reinvested.

Money in and out

Monthly data · as of Jun 30, 2026

PSIL: in the month to Jun 30, 2026, net $4.1m came in, by its SEC filing.

12 months
+$22.3m
215.1% of $10.3m on Jun 30, 2025
Jul 1, 2025 to Jun 30, 2026
monthly, from SEC filings
3 years
+$26.9m
390.8% of $6.9m on Jun 30, 2023
Jul 1, 2023 to Jun 30, 2026
monthly, from SEC filings
5 years
+$45.3m
Jul 1, 2021 to Jun 30, 2026
monthly, from SEC filings
Since Jul 2021
+$45.3m
Jul 1, 2021 to Jun 30, 2026
monthly, from SEC filings

Computed by ETFIQ from the monthly sales and redemptions PSIL files with the SEC on Form N-PORT.

How this is computed

ETFIQ reads no daily data for this fund, so its flows are monthly, and the latest month filed is Jun 2026. Every day and month ETFIQ holds for PSIL, back to Jul 2021, is in its flows file. Flows across every fund · How these flows are computed · Compare PSIL with other funds in the flows tool

Month by month, money in and money outJul 2023 to Jun 2026

PSIL, money in and money out each month from Jul 2023 to Jun 2026: two bars a month, money in above the line and money out below. Every bar is from PSIL’s SEC filings (N-PORT item B.6). Of the 36 months listed, money came in on net in 20 and went out in 3.

Every bar is from PSIL’s SEC filings (N-PORT item B.6). Of the 36 months listed, money came in on net in 20 and went out in 3.

MonthInOutNet
Jun 2026 SEC Form N-PORT+$4.1m$0+$4.1m
May 2026 SEC Form N-PORT+$1.2m$0+$1.2m
Apr 2026 SEC Form N-PORT+$9.2m$0+$9.2m
Mar 2026 SEC Form N-PORT$0$0$0
Feb 2026 SEC Form N-PORT$0$0$0
Jan 2026 SEC Form N-PORT+$2.0m$0+$2.0m
Dec 2025 SEC Form N-PORT+$1.1m$0+$1.1m
Nov 2025 SEC Form N-PORT$0$0$0
Oct 2025 SEC Form N-PORT+$2.0m$0+$2.0m
Sep 2025 SEC Form N-PORT+$1.8m$0+$1.8m
Aug 2025 SEC Form N-PORT$0$0$0
Jul 2025 SEC Form N-PORT+$923k$0+$923k
Jun 2025 SEC Form N-PORT$0$0$0
May 2025 SEC Form N-PORT$0$0$0
Apr 2025 SEC Form N-PORT$0$0$0
Mar 2025 SEC Form N-PORT$0$0$0
Feb 2025 SEC Form N-PORT+$1.3m$0+$1.3m
Jan 2025 SEC Form N-PORT+$1.2m$0+$1.2m
Dec 2024 SEC Form N-PORT+$52k−$218k−$166k
Nov 2024 SEC Form N-PORT+$616k$0+$616k
Oct 2024 SEC Form N-PORT+$3.4m−$4.7m−$1.2m
Sep 2024 SEC Form N-PORT$0−$191−$191
Aug 2024 SEC Form N-PORT$0$0$0
Jul 2024 SEC Form N-PORT$0$0$0
Jun 2024 SEC Form N-PORT+$181k$0+$181k
May 2024 SEC Form N-PORT$0$0$0
Apr 2024 SEC Form N-PORT+$685k$0+$685k
Mar 2024 SEC Form N-PORT+$642k$0+$642k
Feb 2024 SEC Form N-PORT$0$0$0
Jan 2024 SEC Form N-PORT+$150k$0+$150k
Dec 2023 SEC Form N-PORT+$162k$0+$162k
Nov 2023 SEC Form N-PORT$0$0$0
Oct 2023 SEC Form N-PORT+$406k$0+$406k
Sep 2023 SEC Form N-PORT+$278k$0+$278k
Aug 2023 SEC Form N-PORT+$70k$0+$70k
Jul 2023 SEC Form N-PORT+$435k$0+$435k

Most recent first.

How this is computed

N-PORT months: money in is sales plus reinvestments; money out is redemptions.

N-PORT months are the filed sales plus reinvestments less redemptions. Later months add up the daily data; the Source column names any missing day.

Source: ETFIQ, from the fund’s SEC N-PORT filings. Data as of Jun 30, 2026. Updated when the fund files its next report.

PSIL key stats

52-week high, daily closes to Nov 4, 2026 (ETFIQ)$26.80 on Aug 25, 2026
52-week low, daily closes to Nov 4, 2026 (ETFIQ)$15.63 on Feb 5, 2026
Close on Nov 4, 2026, within that range (ETFIQ)$19.66, 36% of the way from the low to the high
Holdings27
Top ten holdings weight69.2%
Range, beta and R-squared computed by ETFIQ from Tiingo daily prices.

Trading

as of Nov 4, 2026
Trading · PSILas of Nov 4, 2026
·
Not scored2 of 6 measured · Nov 4, 2026
0 · Hard to tradeIQ Liquidity Score100 · Trades like a giant
Cost for your order · one way, half its 30-day median spread
$1,000$3.330.33%
$10,000$330.33%
Premium or discount to NAV, Nov 3 close−0.36%
−1%95% of days within ±0.80%+1%
How to tradeLimit: midpoint + 7¢ to buy, midpoint − 7¢ to sell.At the Nov 3 close of $19.51, that’s $19.58 to buy and $19.44 to sell.
Full trading page: components, premium history, dealers →

PSIL for holders outside the US

US tax withheld on dividends, no treaty30%
Treaty rates on dividends (IRS table, read Oct 30, 2026)65 countries, 10% to 30%
PSIL interest-related and short-term gain dividendsnot read by ETFIQ
US estate tax filing threshold, non-resident holders$60,000
Share classDistributing

PSIL is a US fund. Stock of US corporations counts as US property for a non-resident's estate. Facts from the IRS, not tax advice. How withholding and treaties work
Download all holdings

PSIL top ten by weight, 69.2% of the fund, of its 27 equity positions, from the holdings filed for Jun 30, 2026. Source: the fund’s SEC filing.

COMPASS PATHWAYS PLC CMPS 11.45%
ATAIBECKLEY INC ATAI 10.47%
NRX PHARMACEUTICALS INC NRXP 6.07%
CYBIN INC HELP 4.36%
GH RESEARCH PLC GHRS 4.31%
ALKERMES PLC ALKS 4.30%

Source: Holdings filing (SEC Form N-PORT).

About PSIL

Theme (ETFIQ, editorial)Therapeutics and medical devices
First tradedSep 16, 2021
Already in the S&P 500, by weight (ETFIQ)7.8%
Outside the S&P 500, by weight (ETFIQ)92%
Active share vs the S&P 500 (ETFIQ)98.4%
Already in the Nasdaq-100, by weight (ETFIQ)0.0%
Active share vs the Nasdaq-100 (ETFIQ)100.0%
Top ten holdings weight69.2%
Holdings27
Holdings as of (SEC N-PORT)Jun 30, 2026
Top holdingsDEFINIUM THERAPEUTICS INC 12.8%, COMPASS PATHWAYS PLC 11.4%, ATAIBECKLEY INC 10.5%, RELMADA THERAPEUTICS INC 6.8%, NRX PHARMACEUTICALS INC 6.1%, NEUROCRINE BIOSCIENCES INC 4.4%, CYBIN INC 4.3%, GH RESEARCH PLC 4.3%, ALKERMES PLC 4.3%, ALTO NEUROSCIENCE INC 4.2%
Net assets (issuer page, as of Nov 4, 2026)$43mReport
Benchmark (ETFIQ, from its filings)Its own holdings, as of Jun 30, 2026; its shareholder report compares it with the S&P 500 Index, but its daily returns fit VOO's at R-squared 0.148 over the year to Nov 4, 2026 (251 days), under the 0.35 it needs to return to it
PSIL, Jun 30, 2026 to Oct 16, 2026−17.26%
Its book of Jun 30, 2026, the same days (ETFIQ, measured on 81% of the book by weight)−23.68%
Against its own holdings (ETFIQ)+6.43 pts
Stated benchmark (secondary)S&P 500 Index (from its shareholder report), priced by VOO
PSIL, 1 year to Nov 4, 2026 (secondary)+13.9%
VOO, the same days (secondary)+14.8%
Against its stated benchmark, 1 year (secondary)−0.9 pts
Daily R-squared against VOO, 1 year to Nov 4, 2026 (secondary)0.15
Below its all-time high (ETFIQ)−77.8%
Expense ratio (485BPOS XBRL, Oct 28, 2026)1.00%Report
Fee for the part that differs from the S&P 500, active expense ratio (ETFIQ)1.02%
Closest funds by holdings overlapIBRN 10%
Below its all-time high77.8%, high on Sep 22, 2021
How we measure
The top ten holdings are 69% of the fund across 27 positions, as filed for Jun 30, 2026. Over the year to Nov 4, 2026 the fund returned +13.9% with distributions reinvested. It sits 77.8% below its all-time high of Sep 22, 2021.
Holdings from the fund’s latest public SEC N-PORT filing; overlap and active share computed by ETFIQ against the IVV and QQQM books; returns from Tiingo end-of-day prices with distributions reinvested. Method
IQ Investment Committee on PSIL

12 seats on PSIL, as of Nov 4, 2026: 1 Mixed, 5 Challenges, 6 Not enough data.

In the tradition ofJohn BogleBogle-style Low CostChallenges
In the tradition ofBenjamin GrahamGraham-style Margin of SafetyNot enough data
In the tradition ofWarren Buffett & Charlie MungerBuffett & Munger-style QualityNot enough data
In the tradition ofPeter LynchLynch-style Growth at a Reasonable PriceNot enough data
In the tradition ofJohn TempletonTempleton-style Global ContrarianNot enough data
In the tradition ofRay DalioDalio-style All-WeatherChallenges
In the tradition ofHoward MarksMarks-style Cycles & RiskNot enough data
In the tradition ofStanley DruckenmillerDruckenmiller-style Macro & LiquidityChallenges
In the tradition ofDavid SwensenSwensen-style DiversificationChallenges
In the tradition ofCathie WoodWood-style Disruptive InnovationNot enough data
In the tradition ofJesse LivermoreLivermore-style Trend FollowingChallenges
Uses ETFIQ’s measuresThe ETFIQ SkepticETFIQ’s own seatMixed
Put PSIL to the committee →See all seats →No investor named is affiliated with or endorses ETFIQ. Not investment advice.

Questions people ask about PSIL

How much of PSIL is in S&P 500 companies?
By its holdings filed for Jun 30, 2026, 8% of PSIL by weight is stocks the S&P 500 already holds. Its active share against the index is 98%, so that share is the part doing something different.
What does PSIL hold?
27 positions as filed for Jun 30, 2026, with the top ten at 69% of the fund. The largest are DEFINIUM THERAPEUTICS INC at 12.8%, COMPASS PATHWAYS PLC at 11.4%, ATAIBECKLEY INC at 10.5%.
Has PSIL beaten the S&P 500?
Over the year to Nov 4, 2026 PSIL returned +13.9% with distributions reinvested, against +14.8% for the S&P 500, so it finished behind the index by 0.9 points.
What does PSIL cost?
The prospectus expense ratio is 1.00% a year. Because 98% of the fund differs from the S&P 500, the fee on that differing part works out at 1.02%.
Sources and dates
Prices, PSIL and S&P 500 (SPY)Tiingo end-of-day · Nov 4, 2026
Net assets, $43mIssuer page · Nov 4, 2026

Links are sources, not endorsements.

Cite this pageCitation, APA and Markdown

ETFIQ, PSIL, thematic ETFs, data as of Nov 4, 2026. https://etfiq.com/funds/psil

The difference bar for PSIL, redrawn every trading night.

Free to use with attribution for data ETFIQ computes; issuer data stays under its owner's terms. The underlying files are at Open data.

How differently the money is placed, counting weights: one minus the sum of the smaller weight of each security across the fund and the index. 100% means nothing in common; 0% means the index itself. Two funds can hold the same names and still have a high active share if they weight them very differently.
Weight overlap
The share of money two portfolios hold in the same securities at the same weight.
Already in the index
The fund’s weight in securities the S&P 500 holds at all. A fund can be made entirely of index names and still have high active share, because it holds them at different weights.
The weight of the ten largest holdings. Above 50% the fund is a bet on a handful of companies, whatever the theme.
Embed this chart

Free to use with the credit link. Paste this where the chart should go; it updates every trading night.

PSIL: 8% of PSIL's weight is in S&P 500 companies and 92% is outside the index. Holdings as of Jun 30, 2026.
<figure style="margin:0;max-width:640px">
<iframe src="https://etfiq.com/embed/themes/psil/" title="PSIL: 8% of PSIL&#x27;s weight is in S&amp;P 500 companies and 92% is outside the index. Holdings as of Jun 30, 2026." width="640" height="346" loading="lazy" style="border:0;max-width:100%;width:100%"></iframe>
<figcaption style="font:13px/1.5 sans-serif">PSIL: 8% of PSIL&#x27;s weight is in S&amp;P 500 companies and 92% is outside the index. Holdings as of Jun 30, 2026. Data: <a href="https://etfiq.com/funds/psil">ETFIQ</a></figcaption>
</figure>

How to embed ETFIQ charts

Get the ETFIQ Daily

The day's ETF flows, a comparison and one number. Every trading morning. About the Daily

The ETFIQ Daily and our other emails. Unsubscribe from any one in a click. See Privacy.

Snapshot, Nov 4, 2026. More on the tabs above.